1. Introducing a pharmacist-led transmural care program to reduce drug-related problems in orthogeriatric patients: a prospective interventional study
- Author
-
Rachel Bailly, Stephanie Wuyts, Loic Toelen, Tony Mets, Carmen Van Hauwermeiren, Thierry Scheerlinck, Pieter-Jan Cortoos, and Siddhartha Lieten
- Subjects
Interventional study ,Orthogeriatric patients ,Multidisciplinary approach ,Clinical pharmacist ,Medication review ,Drug-related problems ,Geriatrics ,RC952-954.6 - Abstract
Abstract Background Orthogeriatric patients have an increased risk for complications due to underlying comorbidities, chronic drug therapy and frequent treatment changes during hospitalization. The clinical pharmacist (CP) plays a key role in transmural communication concerning polypharmacy to improve continuity of care by the general practitioner (GP) after discharge. In this study, a pharmacist-led transmural care program, tailored to orthogeriatric patients, was evaluated to reduce drug related problems (DRPs) after discharge. Methods An interventional study was performed (pre-period: 1/10/2021-31/12/2021; post-period: 1/01/2022-31/03/2022). Patients (≥ 65 years) from the orthopedic department were included. The pre-group received usual care, the post-group received the pharmacist-led transmural care program. The DRP reduction rate one month after discharge was calculated. Associated factors for the DRP reduction rate were determined in a multiple linear regression analysis. The GP acceptance rate was determined for the proposed interventions, as well as their clinical impact using the Clinical, Economic and Organizational (CLEO) tool. Readmissions one month after discharge were evaluated. Results Overall, 127 patients were included (control n = 61, intervention n = 66). The DRP reduction rate was statistically significantly higher in the intervention group compared to the control group (p
- Published
- 2024
- Full Text
- View/download PDF